Sign In
Buy R
$264.96
+4.58 (+1.76%)
At Close: Jun 04, 2026
Atlantic Power & Infrastructure (AP&I) Emerges as Top Choice for Educational Institutions With Its Flexi(R)-Pave Installations
07:00am, Wednesday, 11'th Sep 2024
Atlantic Power & Infrastructure Corp. (OTC PINK:AWSL) continues to gain momentum with the increasing adoption of its Flexi®-Pave technology by educational institutions across the country. CLEARWATER,
~ Interim Patient Outcomes Demonstrate Significant Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety Profile at Primary 6-month Analysis ~ ~ Preliminary
~ Interim Patient Outcomes Demonstrate Significant Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety Profile at Primary 6-month Analysis ~ ~ Preliminary
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Ryder System, Inc. (NYSE:R). The se
Time Sensitive - Reminder from Levi & Korsinsky, LLP to File Claim for Share of Ryder System, Inc. (R) Settlement Fund Before Deadline
01:30pm, Thursday, 29'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Ryder System, Inc. (NYSE:R). The sett
Ryder System, Inc. (R) Shareholders - L&K, LLP Encourages you to File a Claim Against the Settlement Fund Before Deadline
01:30pm, Thursday, 29'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Ryder System, Inc. (NYSE:R). The sett
Lexaria's Second GLP-1 Human Pilot Study Shows Zero Adverse Events in DehydraTECH-processed Rybelsus(R) Oral Capsules
09:25am, Thursday, 29'th Aug 2024
Absorption improvements appear to continue with DehydraTECH-processed Rybelsus® vs. Rybelsus® tablets even under "fed" conditions DehydraTECH-treated Rybelsus® does absorb through a mouth-melt prod
Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product
06:30am, Thursday, 29'th Aug 2024
Assisi's tPEMF™ technology aligns with Fear Free's mission to “prevent and alleviate fear, anxiety, and stress in pets” ANN ARBOR, MI / ACCESSWIRE / August 29, 2024 / Zomedica Corp. (NYSE Ameri
Rutherrin(R) Increases Efficacy of Chemotherapy for Lung Cancer
07:00am, Wednesday, 28'th Aug 2024
TORONTO, ON / ACCESSWIRE / August 28, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research a
Ryder Earns Top 10 3PL Ranking in Inbound Logistics' 2024 Readers' Choice Awards
06:55am, Wednesday, 28'th Aug 2024
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder System, Inc. (NYSE: R), a leader in supply chain, dedicated transportation, and fleet management solutions, announces its recognition as one of the Top
R Stock Hits 52-Week High on Dividend Strength: More Upside Ahead?
11:40am, Tuesday, 27'th Aug 2024
The Ryder stock appreciates more than 25% in the past six months on multiple tailwinds.
Therma Bright Major Milestone: Portfolio Company Inretio's Preva(R) Device Achieves 3rd Human Trial Success
06:00am, Tuesday, 27'th Aug 2024
Game-Changing Innovation Poised to Transform Stroke and Blood Clot Treatment Therma Bright's Strategic Investment Helps Medical Device Company Demonstrate Efficacy and Safety in Transforming Ischemic
BOULDER, CO / ACCESSWIRE / August 26, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorou
Here's Why Investors Should Retain Ryder (R) Stock for Now
12:05pm, Friday, 23'rd Aug 2024
Ryder (R) rides high on its robust cost-cutting initiatives and solid segmental performance. However, sluggish freight market conditions are a major headwind.
Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)
07:00am, Friday, 23'rd Aug 2024
CAMBRIDGE, MA / ACCESSWIRE / August 23, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for mRESVIA® (mRNA-1345), an mRNA resp
